Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,217
Closed -$203K 1765
2025
Q4
$203K Buy
+6,217
New +$153K ﹤0.01% 1651
2018
Q2
Sell
-12,500
Closed -$456K 875
2018
Q1
$456K Buy
12,500
+3,703
+42% +$114K 0.01% 728
2017
Q4
$249K Buy
+8,797
New +$208K ﹤0.01% 848

Other funds holding AXGN

Joel Greenblatt's AXGN Position: Q1 2026 in Review

Joel Greenblatt sold out of Axogen (AXGN) in Q1 2026, closing a stake of 6,217 shares — an estimated $203K sold.

Joel Greenblatt first reported a position in AXGN in Q4 2017 and held it in 3 quarters. The position peaked at $456K in Q1 2018. 221 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Joel Greenblatt reported no remaining Axogen position as of Q1 2026 after selling out during the quarter.
  • Joel Greenblatt sold 6,217 Axogen shares in Q1 2026, an estimated $203K.
  • Joel Greenblatt first reported a position in Axogen in Q4 2017 and held it in 3 quarters.
  • Joel Greenblatt's Axogen position peaked at $456K in Q1 2018.
  • 221 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.